Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Valve-in-valve TAVR
Author(s): Emily Perdoncin , Gaetano Paone , Isida Byku Added: 2 years ago

Intervention
Advances in Transcatheter Electrosurgery for Treating Valvular Heart Disease
Author(s): Jaffar M Khan , Toby Rogers , Adam B Greenbaum , et al Added: 3 years ago

Vascular Disease and Surgery

Intervention
Managing Failed Transcatheter Aortic Valve Replacement
Author(s): Nils Perrin , Anita W Asgar Added: 2 years ago

Intervention
Jaffar Khan
Research Area(s) / Expertise: Job title: Staff Clinician
Jaffar is an interventional cardiologist and Staff Clinician at the NHLBI, NIH. He has a special interest in structural heart disease innovation. He co-invented transcatheter electrosurgical techniques to cut heart tissue, including LAMPOON to prevent LVOT obstruction from TMVR, BASILICA to prevent coronary obstruction from TAVR, and ELASTIC/ELASTA-Clip to displace a MitraClip to enable TMVR and… View more
EuroPCR 23: 3 Trials That Will Change Your Practice With Dr Mirvat Alasnag
Author(s): Mirvat Alasnag Added: 11 months ago
EuroPCR 23 — We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of three late-breaking trials that are expected to have a impact on interventional science and clinical practice. Trials covered in detail include: EBC TWO Five Year Follow-Up: Two-Stent Vs One for Large Bifurcation Lesions BASILICA Vs Chimney-Stenting for TAVR-Related Coronary… View more

Intervention
EuroPCR 2023: Late-Breaking Science Video Collection
Author(s): D Scott Lim , Sandeep Arunothayaraj , Paul Sorajja Added: 11 months ago
Our regular review seriesView From the Thoraxcenter,hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) dives deep into the late-breaking trials of EuroPCR 2023, spotlighting the impactful data. For short, concise coverage of the key data revealed, our accessibleExpert Interviewswere conducted with select faculty, focussing on the results,… View more

Intervention
View from the Thoraxcenter: What's Hot at EuroPCR 23?
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 11 months ago
Learn the key take-home messages from EuroPCR 2023 with View from the Thoraxcenter hosts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL). In this dynamic video review, Dr Daemen and Prof Van Mieghem cover the top late-breaking science, offering insight into how they will incorporate the data into their clinical practice. What are the top trials of EuroPCR… View more

Intervention
View from the Thoraxcenter: EuroPCR 23 Late-breaking Science Preview
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 11 months ago
Join Prof Nicolas Van Mieghem and Dr Joost Daemen, interventional experts from the Thoraxcenter at Erasmus MC in Rotterdam, as they provide a comprehensive preview of the late-breaking trials and studies that will be presented at EuroPCR 2023. In this dynamic episode, they offer valuable insights into the latest developments in interventional clinical and research science. Studies include:… View more

Intervention
Repeat TAVR Outcomes: Promising Results for Selected Patients with Failed TAVR
Author(s): Raj Makkar Added: 6 months ago
In this insightful interview, investigator, Prof Raj R Makkar(Cedars-Sinai Heart Institute, US) joins us to discuss the outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves. Prof Makkar and his team used the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry to address a series of questions regarding the safety… View more

Intervention
Author(s): Michael N Young , Sammy Elmariah Added: 3 years ago
Severe aortic valve stenosis (AS) is chronic, progressive illness that confers significant morbidity and mortality. Once symptomatic, patients with severe AS will ultimately succumb to the disease if it is not promptly corrected.1 Historically, surgical aortic valve replacement (SAVR) served as the exclusive therapeutic option to correct this mechanical problem.2 However, in 2002, Alain Cribier… View more

Vascular Disease and Surgery

Intervention